| J0897 | Injection, denosumab, 1 mg | 4,080 | $20 | $73.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 410 | $90 | $37.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 180 | $130 | $23.4K |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 170 | $80 | $12.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 130 | $100 | $12.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 180 | $60 | $11.3K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $130 | $11K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 140 | $70 | $9.9K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $170 | $7.9K |
| J0185 | Injection, aprepitant, 1 mg | 5,460 | $1 | $5.5K |